These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11340346)

  • 1. Enhanced expression of plasminogen activator inhibitor 1 in patients with nephrotic syndrome.
    Yoshida Y; Shiiki H; Iwano M; Uyama H; Hamano K; Nishino T; Dohi K
    Nephron; 2001 May; 88(1):24-9. PubMed ID: 11340346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis.
    Hamano K; Iwano M; Akai Y; Sato H; Kubo A; Nishitani Y; Uyama H; Yoshida Y; Miyazaki M; Shiiki H; Kohno S; Dohi K
    Am J Kidney Dis; 2002 Apr; 39(4):695-705. PubMed ID: 11920334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
    Cao YJ; Wu YH; Liu CF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
    J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia.
    Purwosunu Y; Sekizawa A; Koide K; Farina A; Wibowo N; Wiknjosastro GH; Okazaki S; Chiba H; Okai T
    Clin Chem; 2007 Mar; 53(3):399-404. PubMed ID: 17234729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat.
    Liu K; Brändström A; Liu YX; Ny T; Selstam G
    Endocrinology; 1996 May; 137(5):2126-32. PubMed ID: 8612557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
    Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
    Zuo Y; Warnock M; Harbaugh A; Yalavarthi S; Gockman K; Zuo M; Madison JA; Knight JS; Kanthi Y; Lawrence DA
    Sci Rep; 2021 Jan; 11(1):1580. PubMed ID: 33452298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure.
    Wang Y; Pratt JR; Hartley B; Evans B; Zhang L; Sacks SH
    Kidney Int; 1997 Aug; 52(2):371-7. PubMed ID: 9263992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute paraquat intoxication.
    Seok SJ; Kim SJ; Gil HW; Yang JO; Lee EY; Hong SY
    J Korean Med Sci; 2011 Apr; 26(4):474-81. PubMed ID: 21468253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of fibrinogen and fibrinolysis in 10 adults with nephrotic syndrome.
    Gandrille S; Jouvin MH; Toulon P; Remy P; Fiessinger JN; Roncato M; Moatti N; Aiach M
    Thromb Haemost; 1988 Jun; 59(3):445-50. PubMed ID: 3142081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
    Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
    Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms.
    Houard X; Rouzet F; Touat Z; Philippe M; Dominguez M; Fontaine V; Sarda-Mantel L; Meulemans A; Le Guludec D; Meilhac O; Michel JB
    J Pathol; 2007 May; 212(1):20-8. PubMed ID: 17352452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.